...
首页> 外文期刊>Growth hormone and IGF research: Official journal of the Growth Hormone Research Society and the International IGF Research Society >Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy.
【24h】

Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy.

机译:甲状腺激素在垂体功能低下,格雷夫斯病,先天性甲状腺功能低下和孕妇甲状腺疾病中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Although measurement of serum thyroid-stimulating hormone (TSH) is the single best test to diagnose thyroid disorders and monitor treatment, there are certain situations in which the TSH level cannot be used as a guideline. In the diagnosis of children with hypopituitary hypothyroidism, TSH is often "inappropriately" normal. Treatment is aimed at adjusting the l-thyroxine dose to maintain the serum free thyroxine (T4) in the upper half of the normal range for age. In children with Graves' disease, serum TSH can be suppressed for several months after a euthyroid state is restored, so the clinician must rely on serum free T4 and triiodothyronine (T3) levels. Up to 30% of infants and 10% of children with congenital hypothyroidism have a mildly elevated TSH level despite other indications that the thyroid hormone dosage is correct. Such resistance to thyroid hormone at the pituitary gland diminishes with age. Pregnancy is another condition in which serum TSH levels are altered (slightly lower); in this situation, it is the result of elevated human chorionic gonadotropin levels that cross-react with the TSH receptor. This alteration must be taken into account when diagnosing or treating maternal thyroid disorders during pregnancy.
机译:尽管测量血清促甲状腺激素(TSH)是诊断甲状腺疾病和监测治疗的最佳方法,但在某些情况下,TSH水平不能用作指导。在诊断垂体功能减退的儿童时,TSH通常是“不适当地”正常的。治疗的目的是调节l-甲状腺素的剂量,以使血清游离甲状腺素(T4)维持在正常年龄范围的上半部分。在患有Graves病的儿童中,甲状腺功能恢复后,血清TSH可以抑制数月,因此临床医生必须依靠血清中游离T4和三碘甲状腺素(T3)的水平。尽管有其他迹象表明甲状腺激素剂量正确,但高达30%的婴儿和10%的先天性甲状腺功能低下儿童的TSH水平轻度升高。垂体对甲状腺激素的这种抵抗力随着年龄的增长而减弱。怀孕是血清TSH水平改变(略低)的另一种状况。在这种情况下,这是人绒毛膜促性腺激素水平升高与TSH受体发生交叉反应的结果。在怀孕期间诊断或治疗孕妇甲状腺疾病时,必须考虑这种改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号